Advertisement
Home Tags Gout

Tag: Gout

Patients with obstructive sleep apnea (OSA) are at higher risk for developing gout than patients without OSA for more than a year after diagnosis

Patients With Sleep Apnea Have Increased Gout Risk

Among OSA patients, risk for developing gout is highest one to two years after the index date
The American College of Foot and Ankle Surgeons and the American Association of Nurse Practitioners-Orthopedics Specialty Practice Group have issued a new joint clinical consensus statement on the etiology

Consensus Statement Issued on Management of Foot, Ankle Gout

Risk for gouty flares increased with use of thiazide diuretics, excessive alcohol intake
For patients with gout

Nurse-Led Care Efficacious, Cost-Effective for Gout

More patients receiving nurse-led care had serum urate concentrations less than 360 µmol/L at 2 years

The American College of Rheumatology, Oct. 19-24

The 82nd Annual Meeting of the American College of Rheumatology The annual meeting of the American College of Rheumatology was...
For patients with gout

Allopurinol Linked to Reduced Risk for CKD Stage ≥3 in Gout

Allopurinol use is not associated with renal function decline among those with newly diagnosed gout
Diet explains little of the variation in serum urate levels in the general population

Diet Less Important Than Genes for High Serum Urate Levels

Certain foods linked to high or low serum urate levels, but dietary scores have limited contribution
Allopurinol dose escalation is not associated with reductions in mortality risk among patients with gout

Allopurinol Dose Escalation for Gout Doesn’t Improve Mortality

Linked to small increase in mortality; at 2 years, 31 percent of dose escalators achieved serum urate goal
Quarterly canakinumab administration is associated with significantly reduced risk for gout attacks without any change in serum uric acid levels

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β
For patients with gout and cardiovascular disease

ACC: Febuxostat Noninferior to Allopurinol for Gout, CVD

Noninferior for rates of adverse cardiovascular events; tied to higher all-cause, cardiovascular mortality
Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis

Allopurinol Rx More Likely With Eligibility at Diagnosis

More frequent chronic disease reviews needed to assess eligibility for allopurinol